Trial · NCT00489411
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Initial Treatment Period (Weeks 1-5) | STARTED | Arm I/Group A (Duloxetine Then Placebo) | 115 | |
| Initial Treatment Period (Weeks 1-5) | STARTED | Arm II/Group B (Placebo Then Duloxetine) | 116 | |
| Initial Treatment Period (Weeks 1-5) | COMPLETED | Arm I/Group A (Duloxetine Then Placebo) | 87 | |
| Initial Treatment Period (Weeks 1-5) | COMPLETED | Arm II/Group B (Placebo Then Duloxetine) | 94 | |
| Initial Treatment Period (Weeks 1-5) | NOT COMPLETED | Arm I/Group A (Duloxetine Then Placebo) | 28 | |
| Initial Treatment Period (Weeks 1-5) | NOT COMPLETED | Arm II/Group B (Placebo Then Duloxetine) | 22 | |
| Washout Period (Weeks 6-7) | STARTED | Arm I/Group A (Duloxetine Then Placebo) | 87 | |
| Washout Period (Weeks 6-7) | STARTED | Arm II/Group B (Placebo Then Duloxetine) | 94 | |
| Washout Period (Weeks 6-7) | COMPLETED | Arm I/Group A (Duloxetine Then Placebo) | 85 | |
| Washout Period (Weeks 6-7) | COMPLETED | Arm II/Group B (Placebo Then Duloxetine) | 93 | |
| Washout Period (Weeks 6-7) | NOT COMPLETED | Arm I/Group A (Duloxetine Then Placebo) | 2 | |
| Washout Period (Weeks 6-7) | NOT COMPLETED | Arm II/Group B (Placebo Then Duloxetine) | 1 | |
| Crossover Treatment Period (Weeks 8-12) | STARTED | Arm I/Group A (Duloxetine Then Placebo) | 85 | |
| Crossover Treatment Period (Weeks 8-12) | STARTED | Arm II/Group B (Placebo Then Duloxetine) | 93 | |
| Crossover Treatment Period (Weeks 8-12) | COMPLETED | Arm I/Group A (Duloxetine Then Placebo) | 67 | |
| Crossover Treatment Period (Weeks 8-12) | COMPLETED | Arm II/Group B (Placebo Then Duloxetine) | 74 | |
| Crossover Treatment Period (Weeks 8-12) | NOT COMPLETED | Arm I/Group A (Duloxetine Then Placebo) | 18 | |
| Crossover Treatment Period (Weeks 8-12) | NOT COMPLETED | Arm II/Group B (Placebo Then Duloxetine) | 19 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00489411/flow